glutathione
the endogenous redox tripeptide. used for antioxidant, liver, immune, wellness-IV, and skin-brightening claims. route decides the evidence.
tier D · skin · supplement redox cofactor
verdict
the endogenous redox tripeptide. real biology, route-dependent evidence, marketing strength that outruns the outcome data.
if you're asking about IV glutathione drips — the wellness-IV ecosystem charges a premium per session. IV delivery raises levels quickly. regulators warn that efficacy and dosing are not established for skin lightening or general wellness, and safety signals exist around compounding and sterility. raising blood glutathione is not the same as proving better clinical outcomes.
if you're asking oral vs liposomal vs IV — single plain oral doses have poor plasma availability. longer daily oral dosing and liposomal forms can raise measured body stores in small human studies. IV moves levels fastest. that's biomarker movement. the cleaner outcome trials are in the cheaper oral formulations, not in the IV format the longevity-clinic market is built around.
if you came in for skin brightening — as topical or oral skin brightening, the effect looks modest and route-dependent. FDA Philippines, the EU, and several other regulators have specifically issued warnings on IV glutathione for skin lightening. the molecule is broader than the whitening market (real endogenous biology in antioxidant and detoxification pathways), but the strongest consumer claims still outrun the outcome data.
based on published evidence and disclosed clinical practice. not medical advice.
why D-tier
D-tier because the market claims are bigger than the outcome evidence: detox, anti-aging, energy, hangover repair, disease rescue, and cosmetic IV brightening all outrun the data. Not F-tier because the molecule is foundational, oral/liposomal supplementation can move biomarkers, cystic-fibrosis and Parkinson's research exists, and NAC's clinical role proves the glutathione pathway matters. The issue is translation from redox biology to consumer promises.
the core tension
Glutathione is biochemically foundational. That part is not controversial. The question is whether supplemental glutathione changes outcomes, and that answer splits by route and use case. The 1992 single-dose oral study made oral glutathione look dead on arrival. Later longer-duration oral and liposomal studies show measured increases in blood and cellular glutathione pools. But biomarker movement is not the same as clinical proof. IV use is pharmacologically active, while wellness and cosmetic clinics borrow hospital-adjacent language in a weaker evidence and higher-risk zone. Real molecule, real biomarker effects, narrow clinical research signals, overgrown wellness claims.
what it is
glutathione is an endogenous tripeptide of glutamate, cysteine, and glycine, with an unusual gamma-peptide bond. Every cell makes it, and intracellular concentrations sit in the millimolar range. It's the body's primary intracellular antioxidant and a key player in phase II hepatic detoxification.
what it does
endogenous glutathione buffers oxidative stress, regenerates vitamins C and E, supports glutathione-peroxidase and glutathione-transferase systems, and participates in xenobiotic conjugation. Supplemental glutathione is a route problem: a single plain oral dose has poor plasma availability, longer daily oral dosing and liposomal forms can raise measured body stores, and IV delivery raises levels quickly but carries compounding, sterility, and cosmetic-use safety concerns.
origin
identified in the 1880s as a reducing agent in yeast. N-acetylcysteine, a precursor, became the hospital-standard antidote for acetaminophen overdose because it restores hepatic glutathione under crisis conditions. The modern market split into supplement capsules, liposomal products, nebulized/intranasal research, wellness-clinic IVs, and cosmetic IV skin-brightening protocols that drew repeated regulator warnings.
why researchers are interested
people research it for more than whitening: antioxidant status, hangover or liver-support marketing, chemotherapy-adjunct folklore, immune support, Parkinson's and neurodegeneration interest, cystic-fibrosis airway research, skin brightness, and the general IV-drip promise of feeling better fast. Some of those buckets have real biology. Most have weaker outcome evidence than the marketing implies.
does it work
depends what 'work' means. As endogenous biology, absolutely. As a daily oral or liposomal supplement, it can move glutathione biomarkers in small human studies; that is not the same as proving better clinical outcomes in healthy users. As topical or oral skin brightening, the effect looks modest and route-dependent. As IV skin lightening, regulators warn that efficacy and dosing are not established and safety signals exist. The molecule is broader than the whitening market, but the strongest consumer claims still outrun the outcome data.
claims vs the data
- is the master antioxidant in every cell — supported — Basic biochemistry. Endogenous synthesis, universal cellular presence, central role in oxidative stress management and Phase II detoxification.
- oral glutathione can raise body glutathione stores — partially true — A single plain oral dose performs poorly, but a 6-month randomized trial and a small liposomal study reported increases in blood or cellular glutathione markers. Clinical outcomes are still the hard part.
- liposomal glutathione is better absorbed — partially true — Small human data show liposomal glutathione can raise whole-blood, erythrocyte, plasma, and PBMC glutathione markers. The study size is small, so it supports bioavailability more than broad wellness claims.
- glutathione improves immune function — weak — Some immune-marker movement appears in small supplementation studies. That is not the same as proving fewer infections or better clinical immune outcomes in healthy users.
- helps cystic fibrosis lung function — partially true — A meta-analysis of four RCTs reported FEV1 improvement. that is a disease-specific clinical finding, not a generic wellness claim.
- IV or intranasal glutathione helps Parkinson's symptoms — weak — Small studies and case reports exist, but the evidence has not become a standard approved therapy.
- skin brightening works — partially true — Oral and topical trials show modest effects in some sun-exposed areas. The literature does not support dramatic whitening, durable results, or high-dose IV clinic protocols.
- IV glutathione is safe for cosmetic skin lightening — contradicted — Philippines DOH/FDA warnings cite no approved injectable skin-lightening product, no dosing guidelines, and safety concerns. US FDA also flagged endotoxin-related adverse events from compounded injectable glutathione.
- detoxifies the body of heavy metals and toxins — overreach — Glutathione participates in conjugation chemistry. That does not validate broad detox claims in healthy people or replace diagnosis and treatment for toxic exposures.
- glutathione is just a skin-whitening peptide — contradicted — Skin lightening is the loud cosmetic use case, not the whole molecule. The evidence base also runs through oxidative stress, glutathione status, oral and sublingual supplementation trials, liver-disease studies, and injectable safety alerts from contaminated cosmetic use.
key facts
- molecular formula: C10H17N3O6S
- molecular weight: 307.33 Da
- amino acids: 3
- half-life: very short in plasma (minutes); intracellular concentrations in millimolar range
- type: tripeptide (γ-glutamyl-cysteinyl-glycine) with unusual γ-peptide bond
- CAS: 70-18-8
- 54 adults in a 6-month oral glutathione RCT
- 12 subjects in a liposomal glutathione pilot
- 4 RCTs cystic-fibrosis trials in a meta-analysis
- 2019 US FDA compounding alert on injectable glutathione
frequently asked questions
What is glutathione?
Glutathione is an endogenous tripeptide (glutamate-cysteine-glycine) produced naturally in every cell. It is the body's primary intracellular antioxidant and plays central roles in detoxification, immune function, and redox balance.
What does glutathione do?
Endogenous glutathione neutralizes oxidants, supports phase II conjugation, regenerates other antioxidants, and participates in immune and redox signaling. Supplemental glutathione has route-dependent evidence: chronic oral and liposomal products can raise measured glutathione stores, but broad detox, energy, anti-aging, and disease-treatment claims remain much less proven.
How is glutathione typically administered?
Common routes include plain oral capsules, liposomal or sublingual products, topical dermatology formulas, nebulized/intranasal research formulations, and IV wellness or cosmetic protocols. The evidence and risk profile change sharply by route.
What are the side effects of glutathione?
Oral glutathione is generally well tolerated in small studies. IV glutathione carries different risks: hypersensitivity, contamination or endotoxin exposure from compounded injectables, non-sterile injection practice, and regulator-cited concerns around cosmetic skin-lightening protocols, including Stevens-Johnson syndrome and organ-toxicity warnings.
Is glutathione FDA approved?
In the US, oral glutathione is sold as a supplement and there is no FDA-approved injectable glutathione product for skin lightening. The FDA has specifically warned about using dietary-ingredient glutathione powder to compound sterile injectables after adverse events. NAC, a glutathione precursor, has separate FDA-approved drug uses.
How much does glutathione cost?
Oral glutathione supplements and IV wellness-clinic pricing vary widely by route, formulation, and setting. Cost does not solve the evidence problem: sterile injectable quality, route, and clinical endpoint data matter more than the price tag.
related peptides
- ss-31 — mitochondrial antioxidant with real clinical program
- NAD+ — other endogenous cofactor with similar supplement-market dynamics
- ghk-cu — cosmetic peptide with actual evidence for skin effects
reptides grades the research record and cites the literature behind every call. research reference only; not medical advice.